Get the Stockscreener App
70.34
3.29%
-2.39
Intra-Cellular Therapies Inc Stock (ITCI) Forecast
The Intra-Cellular Therapies Inc (ITCI) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $77.46, representing a +10.12% increase from the current price of $70.34. The highest analyst price target is $80.03, and the lowest is $74.88.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month ITCI Price Target
Average 106.39
(+51.25% Upside)
Is Intra-Cellular Therapies Inc (ITCI) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 48.67 | Neutral |
| STOCH(9,6) | 19.41 | Buy |
| STOCHRSI(14) | 27.26 | Neutral |
| MACD(12,26) | 0.9574 | Sell |
| ADX(14) | 22.65 | Neutral |
| William %R | -70.17 | Neutral |
| CCI(14) | -57.97 | Neutral |
Buy: 1
Sell: 1
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
72.66
Sell
|
72.03
Sell
|
| MA20 |
71.29
Sell
|
71.38
Sell
|
| MA50 |
69.24
Buy
|
69.87
Buy
|
| MA100 |
68.91
Buy
|
67.74
Buy
|
| MA200 |
62.46
Buy
|
64.30
Buy
|
Buy: 6
Sell: 4
Neutral: 0
Summary: Buy
According to our latest analysis, ITCI could be considered a Potential Buy, with 17 technical analysis indicators signaling 7 Buy signals, 5 signaling Sell signals and 5 Neutral signals. This might be a good time to open fresh positions on ITCI, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 48.67 indicates that ITCI is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 19.41 indicates that ITCI is oversold. This indicates that ITCI price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 27.26 indicates that ITCI is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 22.65 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -57.97 indicates that ITCI is still oversold but not to an extreme extent.
Long-term ITCI price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Intra-Cellular Therapies Inc financial reports and earnings history, Intra-Cellular Therapies Inc (ITCI) stock could reach $142.97 by 2030, $907.90 by 2040 and $1,155.19 by 2050. See the projected annual prices until 2050 of the Intra-Cellular Therapies Inc stock below:
- Intra-Cellular Therapies Inc (ITCI) is expected to reach an average price of $687.61 in 2035, with a high prediction of $688.50 and a low estimate of $666.04. This indicates an $877.55% rise from the last recorded price of $70.34.
- Intra-Cellular Therapies Inc (ITCI) stock is projected to chart a bullish course in 2040, with an average price target of $906.97, representing an $1,189% surge from its current level. The forecast ranges from a conservative $889.75 to a sky-high $907.90.
- Our analysts predict Intra-Cellular Therapies Inc (ITCI) to jump 1,390% by 2045, soaring from $1,035.60 to an average price of $1,048.25, potentially reaching $1,049.50. While $1,035.60 is the low estimate, the potential upside is significant.
- Intra-Cellular Therapies Inc (ITCI) stock is expected to climb by 2050, reaching an average of $1,153.79, a $1,540% jump from its current level. However, a wide range of estimates exists, with high and low targets of $1,155.19 and $1,132.11, respectively, highlighting the market's uncertainty.
Intra-Cellular Therapies Inc Stock (ITCI) Year by Year Forecast
Intra-Cellular Therapies Inc Stock (ITCI) Price Forecast for 2024
Our forecast for ITCI stock price in 2024 now indicates an average price target of $82.31 with a high forecast of $101.83 and a low forecast of $62.78. The average prediction reflects an increase of +17.01% from the last recorded price of $70.34.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| June, 2024 | $79.51 | $74.88 | $80.03 | +13.03% |
| July, 2024 | $79.82 | $77.97 | $82.44 | +13.47% |
| August, 2024 | $83.73 | $80.37 | $84.48 | +19.03% |
| September, 2024 | $87.59 | $84.43 | $89.29 | +24.52% |
| October, 2024 | $92.15 | $87.52 | $92.42 | +31.00% |
| November, 2024 | $97.22 | $92.89 | $97.85 | +38.21% |
| December, 2024 | $101.71 | $97.11 | $101.83 | +44.59% |
Intra-Cellular Therapies Inc Stock (ITCI) Price Forecast for 2025
Intra-Cellular Therapies Inc Stock (ITCI) is expected to reach an average price of $135.57 in 2025, with a high prediction of $168.26 and a low estimate of $102.88. This indicates an +92.73% rise from the last recorded price of $70.34.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $127.25 | $102.88 | $137.90 | +80.91% |
| February, 2025 | $122.74 | $121.87 | $130.15 | +74.49% |
| March, 2025 | $124.29 | $122.48 | $128.21 | +76.70% |
| April, 2025 | $123.66 | $117.70 | $127.46 | +75.80% |
| May, 2025 | $129.68 | $123.62 | $130.46 | +84.36% |
| June, 2025 | $138.40 | $130.55 | $139.42 | +96.76% |
| July, 2025 | $146.29 | $138.37 | $146.72 | +107.98% |
| August, 2025 | $149.62 | $146.74 | $150.21 | +112.71% |
| September, 2025 | $149.64 | $147.44 | $150.93 | +112.74% |
| October, 2025 | $151.56 | $147.73 | $152.00 | +115.47% |
| November, 2025 | $162.99 | $151.97 | $168.21 | +131.72% |
| December, 2025 | $166.78 | $162.04 | $168.26 | +137.11% |
Intra-Cellular Therapies Inc Stock (ITCI) Price Forecast for 2026
The predicted value for Intra-Cellular Therapies Inc (ITCI) in 2026 is set at an average of $198.17. Estimates vary from a peak of $230.03 to a trough of $166.30, indicating an +181.72% surge from the present price of $70.34.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $170.91 | $166.30 | $172.99 | +142.98% |
| February, 2026 | $178.61 | $170.42 | $178.96 | +153.93% |
| March, 2026 | $187.36 | $178.61 | $188.53 | +166.36% |
| April, 2026 | $197.86 | $186.29 | $198.35 | +181.30% |
| May, 2026 | $198.11 | $191.84 | $199.31 | +181.65% |
| June, 2026 | $197.69 | $193.39 | $200.69 | +181.04% |
| July, 2026 | $208.37 | $196.71 | $209.52 | +196.24% |
| August, 2026 | $216.28 | $208.40 | $218.37 | +207.47% |
| September, 2026 | $220.11 | $216.65 | $222.34 | +212.93% |
| October, 2026 | $216.63 | $215.62 | $221.53 | +207.97% |
| November, 2026 | $220.22 | $212.55 | $220.86 | +213.08% |
| December, 2026 | $229.07 | $220.88 | $230.03 | +225.67% |
Intra-Cellular Therapies Inc Stock (ITCI) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Intra-Cellular Therapies Inc (ITCI) is $265.39, with a high forecast of $301.52 and a low forecast of $229.26. This indicates an +277.30% increase from the last price of $70.34.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $238.75 | $229.26 | $239.23 | +239.42% |
| February, 2027 | $239.72 | $238.03 | $244.55 | +240.80% |
| March, 2027 | $243.38 | $237.69 | $244.95 | +246.00% |
| April, 2027 | $251.11 | $247.21 | $261.32 | +256.99% |
| May, 2027 | $260.58 | $247.50 | $260.84 | +270.46% |
| June, 2027 | $271.73 | $261.36 | $276.52 | +286.30% |
| July, 2027 | $281.65 | $269.68 | $286.15 | +300.41% |
| August, 2027 | $276.72 | $276.25 | $289.30 | +293.40% |
| September, 2027 | $287.34 | $269.57 | $288.74 | +308.50% |
| October, 2027 | $287.82 | $283.15 | $291.92 | +309.18% |
| November, 2027 | $294.27 | $286.96 | $296.45 | +318.36% |
| December, 2027 | $295.05 | $289.92 | $301.52 | +319.46% |
Intra-Cellular Therapies Inc Stock (ITCI) Price Forecast for 2028
In 2028, Intra-Cellular Therapies Inc (ITCI) is projected to reach an average price of $324.18, with a high projection of $357.26 and a low estimate of $291.10. This indicates an +360.87% rise from the last price of $70.34.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $296.91 | $291.29 | $297.07 | +322.11% |
| February, 2028 | $295.65 | $291.10 | $300.79 | +320.32% |
| March, 2028 | $299.57 | $295.56 | $301.23 | +325.89% |
| April, 2028 | $309.95 | $298.71 | $311.31 | +340.65% |
| May, 2028 | $313.14 | $310.17 | $316.54 | +345.18% |
| June, 2028 | $314.27 | $311.64 | $318.18 | +346.79% |
| July, 2028 | $318.81 | $315.02 | $320.82 | +353.25% |
| August, 2028 | $318.92 | $316.93 | $325.65 | +353.40% |
| September, 2028 | $338.04 | $319.06 | $338.17 | +380.58% |
| October, 2028 | $345.86 | $337.74 | $348.65 | +391.70% |
| November, 2028 | $348.66 | $344.56 | $350.08 | +395.68% |
| December, 2028 | $354.48 | $349.06 | $357.26 | +403.96% |
Intra-Cellular Therapies Inc Stock (ITCI) Price Forecast for 2029
The 2029 price forecast for Intra-Cellular Therapies Inc Stock (ITCI) is $277.14 on average, with a high prediction of $421.92 and a low estimate of $132.37. This represents an +294.00% increase from the previous price of $70.34.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $357.78 | $353.13 | $359.03 | +408.64% |
| February, 2029 | $354.82 | $353.74 | $358.96 | +404.44% |
| March, 2029 | $358.61 | $355.48 | $363.48 | +409.83% |
| April, 2029 | $361.07 | $356.81 | $362.19 | +413.32% |
| May, 2029 | $365.64 | $355.77 | $368.95 | +419.82% |
| June, 2029 | $378.85 | $366.02 | $379.02 | +438.59% |
| July, 2029 | $391.45 | $376.73 | $393.99 | +456.51% |
| August, 2029 | $391.94 | $387.07 | $394.75 | +457.21% |
| September, 2029 | $398.59 | $391.21 | $404.08 | +466.66% |
| October, 2029 | $402.22 | $395.55 | $403.23 | +471.83% |
| November, 2029 | $409.40 | $400.91 | $421.92 | +482.02% |
| December, 2029 | $132.67 | $132.37 | $414.87 | +88.61% |
Intra-Cellular Therapies Inc Stock (ITCI) Price Forecast for 2030
Intra-Cellular Therapies Inc Stock (ITCI) is expected to reach an average price of $184.02 in 2030, with a high forecast of $234.72 and a low forecast of $133.33. This signifies an +161.62% surge from the last price of $70.34.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $142.19 | $133.33 | $142.97 | +102.15% |
| February, 2030 | $148.39 | $143.82 | $149.90 | +110.96% |
| March, 2030 | $152.84 | $148.42 | $153.30 | +117.29% |
| April, 2030 | $160.87 | $154.45 | $161.16 | +128.70% |
| May, 2030 | $169.40 | $162.67 | $169.58 | +140.83% |
| June, 2030 | $178.28 | $170.62 | $178.50 | +153.46% |
| July, 2030 | $189.11 | $180.05 | $189.56 | +168.85% |
| August, 2030 | $199.25 | $189.93 | $200.33 | +183.27% |
| September, 2030 | $220.20 | $212.42 | $232.23 | +213.05% |
| October, 2030 | $226.81 | $221.48 | $227.53 | +222.45% |
| November, 2030 | $226.87 | $225.23 | $232.30 | +222.54% |
| December, 2030 | $233.53 | $224.46 | $234.72 | +232.00% |
2.43%
0.26%
Cap:
|
Volume (24h):